H. Montero

Serological levels of mutated p53 protein are highly detected at early stages in breast cancer patients.

G. Balogh, D. Mailo, E. Barutta, 2010, Experimental and therapeutic medicine.

HER 2 / neu protein expression and fine needle breast aspiration from Argentinean patients with non-palpable breast lesions

G. Balogh, H. Nardi, M. M. Corte, 2010 .

Mutant p 53 protein in serum could be used as a molecular marker in human breast cancer

L. Shulman, G. Balogh, D. Mailo, 2006 .

Mutant p53 protein in serum could be used as a molecular marker in human breast cancer.

L. Shulman, G. Balogh, D. Mailo, 2006, International journal of oncology.

HER2/neu protein expression and fine needle breast aspiration from Argentinean patients with non-palpable breast lesions.

G. Balogh, H. Nardi, M. M. Corte, 2010, Experimental and therapeutic medicine.